[
  {
    "ts": "2026-02-17T13:30:34+00:00",
    "headline": "Ocular Therapeutix stock news: Why positive data led to a 25% drop",
    "summary": "Investing.com -- Ocular Therapeutix (NASDAQ:OCUL) stock fell 25% Tuesday after the company reported top-line results from its Phase 3 SOL-1 superiority trial for Axpaxli in wet age-related macular degeneration (AMD). EyePoint (NASDAQ:EYPT) shares dropped 15%, while Regeneron Pharmaceuticals (NASDAQ:REGN) shares were flat.",
    "url": "https://finance.yahoo.com/news/ocular-therapeutix-stock-news-why-133034174.html",
    "source": "Investing.com",
    "provider": "yfinance",
    "raw": {
      "id": "45ab388a-ea97-3c9b-be8e-d43bcfd80fe4",
      "content": {
        "id": "45ab388a-ea97-3c9b-be8e-d43bcfd80fe4",
        "contentType": "STORY",
        "title": "Ocular Therapeutix stock news: Why positive data led to a 25% drop",
        "description": "",
        "summary": "Investing.com -- Ocular Therapeutix (NASDAQ:OCUL) stock fell 25% Tuesday after the company reported top-line results from its Phase 3 SOL-1 superiority trial for Axpaxli in wet age-related macular degeneration (AMD). EyePoint (NASDAQ:EYPT) shares dropped 15%, while Regeneron Pharmaceuticals (NASDAQ:REGN) shares were flat.",
        "pubDate": "2026-02-17T13:30:34Z",
        "displayTime": "2026-02-17T13:30:34Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Investing.com",
          "url": "https://www.investing.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/ocular-therapeutix-stock-news-why-133034174.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/ocular-therapeutix-stock-news-why-133034174.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "OCUL"
            },
            {
              "symbol": "REGN"
            },
            {
              "symbol": "EYPT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]